Belzutifan is usually a CYP2C19 substrate. Coadministration with CYP2C19 inhibitors may well boost incidence or severity of adverse effects. Keep an eye on for anemia and hypoxia and lessen belzutifan dose as encouraged.Wisor and Eriksson (2005) examined the consequences of modafinil in circumstances of altered dopamine and norepinephrine levels. T